“…Among high-income countries, the estimated proportion of gross domestic product associated with osteoarthritis-related medical costs ranges from 1 to 2.5% ( Hunter et al, 2014 ; Murphy et al, 2018 ). Personal costs include those incurred by loss of employment, premature retirement, and loss of income and personal savings ( Gupta et al, 2005 ; Schofield et al, 2013 , 2018 ; Woolf, 2015 ; Hunter and Bierma-Zeinstra, 2019 ), which increases the demand for sickness benefits and disability pensions ( Woolf, 2015 ; Törmälehto et al, 2019 ). Further indirect costs result from factors such as absenteeism, presenteeism, reduced productivity, caregiver time, and premature mortality ( Hunter et al, 2014 ; Xie et al, 2016 ).…”